1910
AI-native biotech company providing a multimodal, modality-agnostic AI infrastructure for pharma. Its ITO™ platform integrates wet lab, computational, and proxy data to help companies reliably drug the undruggable.
Where 1910 ranks
Current edition · updated Oct 20, 2026About 1910
AI-native biotech company providing a multimodal, modality-agnostic AI infrastructure for pharma. Its ITO™ platform integrates wet lab, computational, and proxy data to help companies reliably drug the undruggable.
Products
Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...
AI model for unlocking macrocyclic peptide drugs using massively parallel biological assays.
AI model that unlocks stereochemistry and beyond rule of 5 to predict CNS penetration of small molecules.
A SOTA collection of hundreds of AI/ML models with a Multi-AI Agent System to solve the multi-parameter optimization problem of drug discovery.
Security and compliance
No security details published yet
1910 hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim 1910